30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Biohaven Pharmaceutical Holding Company Ltd (BHVN)

Track

The most recent insider transaction occurred on August 19, 2022, with a significant buy transaction by Gregory Bailey. Prior to this, several planned sales were executed by executives including George C. Clark and Elyse Stock in late 2021 and early 2022. The overall insider activity shows a mix of buying and selling over the observed period.
Stock chart
Ticker: BHVN Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Bailey Gregory
1 purchase — total 5,625,676 USD
Buy 19 Aug 2022
Value US$4,839,648.67 | Price 378.42 | Shares 58,986
Planned sale 10 May 2022
Value US$499,659.71 | Price 20.59 | Shares 82,588
Planned sale 19 Jan 2022
Value US$420,180.29 | Price 119.37 | Shares 3,520
Planned sale 19 Jan 2022
Value US$59,024.00 | Price 118.05 | Shares 500
Planned sale 19 Jan 2022
Value US$250,484.81 | Price 116.02 | Shares 2,159
Planned sale 19 Jan 2022
Value US$367,314.04 | Price 114.93 | Shares 3,196
Planned sale 20 Dec 2021
Value US$1,500,000.00 | Price 125.00 | Shares 12,000
Planned sale 20 Dec 2021
Value US$237,153.60 | Price 123.84 | Shares 1,915
Planned sale 15 Dec 2021
Value US$168,700.79 | Price 106.17 | Shares 1,589
Planned sale 15 Dec 2021
Value US$2,143,426.46 | Price 105.43 | Shares 20,330
Planned sale 14 Dec 2021
Value US$728,761.54 | Price 105.02 | Shares 6,939
Planned sale 10 Dec 2021
Value US$143,516.42 | Price 103.85 | Shares 1,382
Planned sale 10 Dec 2021
Value US$2,412,161.87 | Price 102.70 | Shares 23,487
Planned sale 10 Dec 2021
Value US$1,033,467.36 | Price 102.01 | Shares 10,131
Sale 29 Nov 2021
Value US$1,302,315.80 | Price 113.25 | Shares 11,499
Sale 29 Nov 2021
Value US$1,464,117.19 | Price 112.40 | Shares 13,026
Sale 16 Nov 2021
Value US$833,711.49 | Price 117.87 | Shares 7,073
Sale 16 Nov 2021
Value US$2,127,173.02 | Price 116.69 | Shares 18,230
Sale 16 Nov 2021
Value US$1,441,500.54 | Price 115.90 | Shares 12,437
Buy 10 Nov 2021
Value US$136,862.00 | Price 123.30 | Shares 1,110
Buy 10 Nov 2021
Value US$477,480.00 | Price 122.75 | Shares 3,890
Buy 17 Mar 2021
Value US$999,932.00 | Price 76.00 | Shares 13,157
Buy 2 Mar 2021
Value US$851,370.00 | Price 85.14 | Shares 10,000
Buy 23 Nov 2020
Value US$447,736.50 | Price 89.55 | Shares 5,000
Planned sale 2 Nov 2020
Value US$101,005.06 | Price 77.70 | Shares 1,300
Planned sale 2 Nov 2020
Value US$308,799.27 | Price 77.01 | Shares 4,010
Planned sale 2 Nov 2020
Value US$1,876,872.08 | Price 76.02 | Shares 24,690
Planned sale 23 Oct 2020
Value US$16,948.00 | Price 79.94 | Shares 212
Planned sale 23 Oct 2020
Value US$803,918.05 | Price 78.89 | Shares 10,191
Planned sale 22 Oct 2020
Value US$247,632.03 | Price 79.88 | Shares 3,100
Planned sale 22 Oct 2020
Value US$1,704,720.24 | Price 79.41 | Shares 21,466
Planned sale 19 Oct 2020
Value US$359,655.34 | Price 78.98 | Shares 4,554
Planned sale 16 Oct 2020
Value US$295,638.12 | Price 78.88 | Shares 3,748
Planned sale 12 Oct 2020
Value US$530,740.45 | Price 78.87 | Shares 6,729
Planned sale 8 Oct 2020
Value US$190,300.08 | Price 77.42 | Shares 2,458
Planned sale 8 Oct 2020
Value US$1,205,938.26 | Price 76.42 | Shares 15,781
Planned sale 8 Oct 2020
Value US$397,843.66 | Price 75.62 | Shares 5,261
Buy 21 Sep 2020
Value US$196,828.50 | Price 59.25 | Shares 3,322
Buy 11 Sep 2020
Value US$393,983.97 | Price 59.00 | Shares 6,678
Buy 11 Aug 2020
Value US$936,093.26 | Price 61.87 | Shares 15,129
Buy 11 Aug 2020
Value US$445,567.61 | Price 61.28 | Shares 7,271
Buy 11 Aug 2020
Value US$156,823.94 | Price 60.32 | Shares 2,600
Planned sale 8 Jul 2020
Value US$454,888.24 | Price 75.93 | Shares 5,991
Planned sale 8 Jul 2020
Value US$3,305,876.86 | Price 75.12 | Shares 44,009
Planned sale 8 Jul 2020
Value US$209,144.51 | Price 75.29 | Shares 2,778
Planned sale 8 Jul 2020
Value US$4,185,745.25 | Price 75.25 | Shares 55,626
Planned sale 24 Jun 2020
Value US$168,224.80 | Price 70.24 | Shares 2,395
Planned sale 24 Jun 2020
Value US$110,864.96 | Price 69.29 | Shares 1,600
Planned sale 23 Jun 2020
Value US$62,779.31 | Price 75.18 | Shares 835
Planned sale 23 Jun 2020
Value US$4,719,256.86 | Price 74.60 | Shares 63,257
Planned sale 23 Jun 2020
Value US$1,775,368.92 | Price 73.72 | Shares 24,084
Planned sale 23 Jun 2020
Value US$979,026.66 | Price 72.70 | Shares 13,467
Planned sale 23 Jun 2020
Value US$322,431.12 | Price 75.05 | Shares 4,296
Planned sale 22 Jun 2020
Value US$3,618,011.70 | Price 73.64 | Shares 49,132
Planned sale 22 Jun 2020
Value US$1,506,202.24 | Price 72.91 | Shares 20,659
Planned sale 22 Jun 2020
Value US$758,961.16 | Price 72.01 | Shares 10,540
Planned sale 19 Jun 2020
Value US$74,015.96 | Price 75.07 | Shares 986
Planned sale 19 Jun 2020
Value US$32,193.39 | Price 75.22 | Shares 428
Planned sale 19 Jun 2020
Value US$1,666,267.85 | Price 73.78 | Shares 22,584
Planned sale 19 Jun 2020
Value US$886,618.52 | Price 72.93 | Shares 12,157
Planned sale 19 Jun 2020
Value US$1,568,935.03 | Price 71.98 | Shares 21,798
Planned sale 19 Jun 2020
Value US$4,129,854.59 | Price 70.91 | Shares 58,238
Planned sale 19 Jun 2020
Value US$1,879,792.79 | Price 70.10 | Shares 26,814
Planned sale 19 Jun 2020
Value US$1,519,094.35 | Price 69.01 | Shares 22,012
Planned sale 18 Jun 2020
Value US$106,467.48 | Price 76.05 | Shares 1,400
Planned sale 18 Jun 2020
Value US$4,508,822.08 | Price 75.25 | Shares 59,914
Planned sale 17 Jun 2020
Value US$28,081.16 | Price 70.20 | Shares 400
Planned sale 17 Jun 2020
Value US$1,684,869.60 | Price 70.20 | Shares 24,000
Planned sale 16 Jun 2020
Value US$20,825.01 | Price 69.42 | Shares 300
Planned sale 16 Jun 2020
Value US$1,732,457.61 | Price 68.73 | Shares 25,208
Planned sale 16 Jun 2020
Value US$2,167,514.83 | Price 67.90 | Shares 31,920
Planned sale 16 Jun 2020
Value US$172,161.71 | Price 66.94 | Shares 2,572
Planned sale 15 Jun 2020
Value US$1,075,800.98 | Price 68.10 | Shares 15,797
Planned sale 15 Jun 2020
Value US$1,262,557.24 | Price 67.51 | Shares 18,703
Planned sale 15 Jun 2020
Value US$2,267,872.20 | Price 66.05 | Shares 34,336
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-08-22 2022-08-19 B Purchase
3.7
Bailey Gregory
Non-Executive Director
58,986 -20.3%
378.42
US$4,839,649 		58,986 -20.3% 378.42 US$4,839,649
2022-05-12 2022-05-10 PlS Planned sale
3.2
Clark George C.

VP, Chief Accounting Officer

Officer
82,588 +39.2%
20.59
US$499,660 		82,588 +39.2% 20.59 US$499,660
2022-01-24 2022-01-19 PlS Planned sale
3.2
Clark George C.

VP, Chief Accounting Officer

Officer
86,958 -49.3%
216.15
US$1,353,717 		86,958 -49.3% 216.15 US$1,353,717
2022-01-24 2022-01-19 PlS Planned sale
3.2
Clark George C.

VP, Chief Accounting Officer

Officer
500 -5.0%
118.05
US$59,024 		500 -5.0% 118.05 US$59,024
2022-01-24 2022-01-19 PlS Planned sale
3.2
Clark George C.

VP, Chief Accounting Officer

Officer
2,159 -17.7%
116.02
US$250,485 		2,159 -17.7% 116.02 US$250,485
2022-01-24 2022-01-19 PlS Planned sale
3.2
Clark George C.

VP, Chief Accounting Officer

Officer
3,196 -20.8%
114.93
US$367,314 		3,196 -20.8% 114.93 US$367,314
2021-12-22 2021-12-20 PlS Planned sale
2.4
GREGORY JULIA P
Non-Executive Director
12,000 -100.0%
125.00
US$1,500,000 		12,000 -100.0% 125.00 US$1,500,000
2021-12-22 2021-12-20 PlS Planned sale
3.2
Clark George C.

VP, Chief Accounting Officer

Officer
1,915 -18.9%
123.84
US$237,154 		1,915 -18.9% 123.84 US$237,154
2021-12-16 2021-12-15 PlS Planned sale
Stock Elyse

Chief Medical Officer

Officer
1,589 -17.5%
106.17
US$168,701 		1,589 -17.5% 106.17 US$168,701
2021-12-16 2021-12-15 PlS Planned sale
Stock Elyse

Chief Medical Officer

Officer
20,330 -69.2%
105.43
US$2,143,426 		20,330 -69.2% 105.43 US$2,143,426
2021-12-16 2021-12-14 PlS Planned sale
Stock Elyse

Chief Medical Officer

Officer
6,939 -48.2%
105.02
US$728,762 		6,939 -48.2% 105.02 US$728,762
2021-12-10 2021-12-10 PlS Planned sale
0.5
Engelhart James

Chief Financial Officer

Officer
1,382 -11.0%
103.85
US$143,516 		1,382 -11.0% 103.85 US$143,516
2021-12-10 2021-12-10 PlS Planned sale
0.5
Engelhart James

Chief Financial Officer

Officer
23,487 -65.1%
102.70
US$2,412,162 		23,487 -65.1% 102.70 US$2,412,162
2021-12-10 2021-12-10 PlS Planned sale
0.5
Engelhart James

Chief Financial Officer

Officer
10,131 -21.9%
102.01
US$1,033,467 		10,131 -21.9% 102.01 US$1,033,467
2021-12-01 2021-11-29 S Sale
3.7
Doogan Declan
Non-Executive Director
11,499 -1.3%
113.25
US$1,302,316 		11,499 -1.3% 113.25 US$1,302,316
2021-12-01 2021-11-29 S Sale
3.7
Doogan Declan
Non-Executive Director
13,026 -1.5%
112.40
US$1,464,117 		13,026 -1.5% 112.40 US$1,464,117
2021-11-17 2021-11-16 S Sale
3.7
Doogan Declan
Non-Executive Director
7,073 -0.8%
117.87
US$833,711 		7,073 -0.8% 117.87 US$833,711
2021-11-17 2021-11-16 S Sale
3.7
Doogan Declan
Non-Executive Director
18,230 -2.0%
116.69
US$2,127,173 		18,230 -2.0% 116.69 US$2,127,173
2021-11-17 2021-11-16 S Sale
3.7
Doogan Declan
Non-Executive Director
12,437 -1.3%
115.90
US$1,441,501 		12,437 -1.3% 115.90 US$1,441,501
2021-11-10 2021-11-10 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
1,110 +0.0%
123.30
US$136,862 		1,110 +0.0% 123.30 US$136,862
2021-11-10 2021-11-10 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
3,890 +0.2%
122.75
US$477,480 		3,890 +0.2% 122.75 US$477,480
2021-03-17 2021-03-17 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
13,157 +0.5%
76.00
US$999,932 		13,157 +0.5% 76.00 US$999,932
2021-03-03 2021-03-02 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
10,000 +0.4%
85.14
US$851,370 		10,000 +0.4% 85.14 US$851,370
2020-11-23 2020-11-23 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
5,000 +0.2%
89.55
US$447,736 		5,000 +0.2% 89.55 US$447,736
2020-11-04 2020-11-02 PlS Planned sale
JONES WILLIAM A JR

CCO-Migraine & Common Disease

Officer
1,300 -42.6%
77.70
US$101,005 		1,300 -42.6% 77.70 US$101,005
2020-11-04 2020-11-02 PlS Planned sale
JONES WILLIAM A JR

CCO-Migraine & Common Disease

Officer
4,010 -56.8%
77.01
US$308,799 		4,010 -56.8% 77.01 US$308,799
2020-11-04 2020-11-02 PlS Planned sale
JONES WILLIAM A JR

CCO-Migraine & Common Disease

Officer
24,690 -77.8%
76.02
US$1,876,872 		24,690 -77.8% 76.02 US$1,876,872
2020-10-23 2020-10-23 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
212 -0.0%
79.94
US$16,948 		212 -0.0% 79.94 US$16,948
2020-10-23 2020-10-23 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
10,191 -0.4%
78.89
US$803,918 		10,191 -0.4% 78.89 US$803,918
2020-10-23 2020-10-22 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
3,100 -0.1%
79.88
US$247,632 		3,100 -0.1% 79.88 US$247,632
2020-10-23 2020-10-22 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
21,466 -0.8%
79.41
US$1,704,720 		21,466 -0.8% 79.41 US$1,704,720
2020-10-21 2020-10-19 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
4,554 -0.2%
78.98
US$359,655 		4,554 -0.2% 78.98 US$359,655
2020-10-21 2020-10-16 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
3,748 -0.1%
78.88
US$295,638 		3,748 -0.1% 78.88 US$295,638
2020-10-14 2020-10-12 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
6,729 -0.3%
78.87
US$530,740 		6,729 -0.3% 78.87 US$530,740
2020-10-09 2020-10-08 PlS Planned sale
Gentile Kimberly

SVP, Clinical Operations

Officer
2,458 -40.3%
77.42
US$190,300 		2,458 -40.3% 77.42 US$190,300
2020-10-09 2020-10-08 PlS Planned sale
Gentile Kimberly

SVP, Clinical Operations

Officer
15,781 -72.1%
76.42
US$1,205,938 		15,781 -72.1% 76.42 US$1,205,938
2020-10-09 2020-10-08 PlS Planned sale
Gentile Kimberly

SVP, Clinical Operations

Officer
5,261 -19.4%
75.62
US$397,844 		5,261 -19.4% 75.62 US$397,844
2020-09-22 2020-09-21 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
3,322 +0.1%
59.25
US$196,828 		3,322 +0.1% 59.25 US$196,828
2020-09-14 2020-09-11 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
6,678 +0.3%
59.00
US$393,984 		6,678 +0.3% 59.00 US$393,984
2020-08-12 2020-08-11 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
15,129 +0.6%
61.87
US$936,093 		15,129 +0.6% 61.87 US$936,093
2020-08-12 2020-08-11 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
7,271 +0.3%
61.28
US$445,568 		7,271 +0.3% 61.28 US$445,568
2020-08-12 2020-08-11 B Purchase
4.2
CHILDS JOHN W
Non-Executive Director
2,600 +0.1%
60.32
US$156,824 		2,600 +0.1% 60.32 US$156,824
2020-07-10 2020-07-08 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
5,991 -0.2%
75.93
US$454,888 		5,991 -0.2% 75.93 US$454,888
2020-07-10 2020-07-08 PlS Planned sale
0.5
Berman Robert

Special Projects & Med Ovrsght

Officer
2,778 -89.1%
75.29
US$209,145 		2,778 -89.1% 75.29 US$209,145
2020-07-10 2020-07-08 PlS Planned sale
0.5
Berman Robert

Special Projects & Med Ovrsght

Officer
55,626 -94.7%
75.25
US$4,185,745 		55,626 -94.7% 75.25 US$4,185,745
2020-07-10 2020-07-08 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
44,009 -1.7%
75.12
US$3,305,877 		44,009 -1.7% 75.12 US$3,305,877
2020-06-25 2020-06-24 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
2,395 -0.1%
70.24
US$168,225 		2,395 -0.1% 70.24 US$168,225
2020-06-25 2020-06-24 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
1,600 -0.1%
69.29
US$110,865 		1,600 -0.1% 69.29 US$110,865
2020-06-25 2020-06-23 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
835 -0.0%
75.18
US$62,779 		835 -0.0% 75.18 US$62,779
2020-06-25 2020-06-23 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
63,257 -2.3%
74.60
US$4,719,257 		63,257 -2.3% 74.60 US$4,719,257
2020-06-25 2020-06-23 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
24,084 -0.9%
73.72
US$1,775,369 		24,084 -0.9% 73.72 US$1,775,369
2020-06-25 2020-06-23 PlS Planned sale
0.5
Berman Robert

Special Projects & Med Ovrsght

Officer
4,296 -92.6%
75.05
US$322,431 		4,296 -92.6% 75.05 US$322,431
2020-06-25 2020-06-23 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
13,467 -0.5%
72.70
US$979,027 		13,467 -0.5% 72.70 US$979,027
2020-06-22 2020-06-22 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
49,132 -1.8%
73.64
US$3,618,012 		49,132 -1.8% 73.64 US$3,618,012
2020-06-22 2020-06-22 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
20,659 -0.7%
72.91
US$1,506,202 		20,659 -0.7% 72.91 US$1,506,202
2020-06-22 2020-06-22 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
10,540 -0.4%
72.01
US$758,961 		10,540 -0.4% 72.01 US$758,961
2020-06-22 2020-06-19 PlS Planned sale
0.5
Berman Robert

Special Projects & Med Ovrsght

Officer
986 -74.3%
75.07
US$74,016 		986 -74.3% 75.07 US$74,016
2020-06-22 2020-06-19 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
428 -0.0%
75.22
US$32,193 		428 -0.0% 75.22 US$32,193
2020-06-22 2020-06-19 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
22,584 -0.8%
73.78
US$1,666,268 		22,584 -0.8% 73.78 US$1,666,268
2020-06-22 2020-06-19 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
12,157 -0.4%
72.93
US$886,619 		12,157 -0.4% 72.93 US$886,619
2020-06-22 2020-06-19 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
21,798 -0.8%
71.98
US$1,568,935 		21,798 -0.8% 71.98 US$1,568,935
2020-06-22 2020-06-19 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
58,238 -2.0%
70.91
US$4,129,855 		58,238 -2.0% 70.91 US$4,129,855
2020-06-22 2020-06-19 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
26,814 -0.9%
70.10
US$1,879,793 		26,814 -0.9% 70.10 US$1,879,793
2020-06-22 2020-06-19 PlS Planned sale
3.7
Bailey Gregory
Non-Executive Director
22,012 -0.7%
69.01
US$1,519,094 		22,012 -0.7% 69.01 US$1,519,094
2020-06-22 2020-06-18 PlS Planned sale
0.5
Berman Robert

Special Projects & Med Ovrsght

Officer
1,400 -80.4%
76.05
US$106,467 		1,400 -80.4% 76.05 US$106,467
2020-06-22 2020-06-18 PlS Planned sale
0.5
Berman Robert

Special Projects & Med Ovrsght

Officer
59,914 -97.2%
75.25
US$4,508,822 		59,914 -97.2% 75.25 US$4,508,822
2020-06-18 2020-06-17 PlS Planned sale
Gentile Kimberly

SVP, Clinical Operations

Officer
400 -9.9%
70.20
US$28,081 		400 -9.9% 70.20 US$28,081
2020-06-17 2020-06-17 PlS Planned sale
Gentile Kimberly

SVP, Clinical Operations

Officer
24,000 -86.8%
70.20
US$1,684,870 		24,000 -86.8% 70.20 US$1,684,870
2020-06-17 2020-06-16 PlS Planned sale
3.7
Doogan Declan
Non-Executive Director
300 -0.0%
69.42
US$20,825 		300 -0.0% 69.42 US$20,825
2020-06-17 2020-06-16 PlS Planned sale
3.7
Doogan Declan
Non-Executive Director
25,208 -3.9%
68.73
US$1,732,458 		25,208 -3.9% 68.73 US$1,732,458
2020-06-17 2020-06-16 PlS Planned sale
3.7
Doogan Declan
Non-Executive Director
31,920 -4.7%
67.90
US$2,167,515 		31,920 -4.7% 67.90 US$2,167,515
2020-06-17 2020-06-16 PlS Planned sale
3.7
Doogan Declan
Non-Executive Director
2,572 -0.4%
66.94
US$172,162 		2,572 -0.4% 66.94 US$172,162
2020-06-17 2020-06-15 PlS Planned sale
3.7
Doogan Declan
Non-Executive Director
15,797 -2.3%
68.10
US$1,075,801 		15,797 -2.3% 68.10 US$1,075,801
2020-06-17 2020-06-15 PlS Planned sale
3.7
Doogan Declan
Non-Executive Director
18,703 -2.6%
67.51
US$1,262,557 		18,703 -2.6% 67.51 US$1,262,557
2020-06-17 2020-06-15 PlS Planned sale
3.7
Doogan Declan
Non-Executive Director
34,336 -4.5%
66.05
US$2,267,872 		34,336 -4.5% 66.05 US$2,267,872
Explore more

More insider trading research around Biohaven Pharmaceutical Holding Company Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America